These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3517417)

  • 61. [Cell differentiation induction therapy in leukemia].
    Tashima M; Sawada H; Okazaki T; Mochizuki T; Ishikura H; Izumi Y; Uchino H
    Nihon Rinsho; 1986 Feb; 44(2):388-94. PubMed ID: 3517417
    [No Abstract]   [Full Text] [Related]  

  • 62. [Fundamentals of leukemia differentiation therapy].
    Hozumi M
    Rinsho Ketsueki; 1992 May; 33(5):561-72. PubMed ID: 1630006
    [No Abstract]   [Full Text] [Related]  

  • 63. Potential applications of cytodifferentiation therapy in hematologic malignancies.
    Breitman TR; Chen ZX; Takahashi N
    Semin Hematol; 1994 Oct; 31(4 Suppl 5):18-25. PubMed ID: 7831581
    [TBL] [Abstract][Full Text] [Related]  

  • 64. To overcome pharmacologic and cytokinetic resistance to cytarabine in the treatment of acute myelogenous leukemia by using recombinant interleukin-3?
    Brach MA; Henschler R; Mertelsmann R; Herrmann F
    Semin Hematol; 1991 Jul; 28(3 Suppl 4):39-43. PubMed ID: 1780751
    [No Abstract]   [Full Text] [Related]  

  • 65. [Experimental model for differentiation therapy of leukemia].
    Hayashi M
    Gan To Kagaku Ryoho; 1993 Jun; 20(8):1009-15. PubMed ID: 8099785
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Duration of the dormant state in an established cell line of human hematopoietic cells.
    Clarkson BD; Fried J; Chou TC; Strife A; Ferguson R; Sullivan S; Kitahara T; Oyama A
    Cancer Res; 1977 Dec; 37(12):4506-22. PubMed ID: 336195
    [No Abstract]   [Full Text] [Related]  

  • 67. Properties of antileukaemic drugs.
    Brusamolino E
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():30-3. PubMed ID: 2653515
    [No Abstract]   [Full Text] [Related]  

  • 68. Acute promyelocytic leukemia: biology and treatment.
    Fenaux P; Chomienne C; Degos L
    Semin Oncol; 1997 Feb; 24(1):92-102. PubMed ID: 9045308
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Differentiating agents in the treatment of leukemia and myelodysplastic syndromes.
    Degos L
    Leuk Res; 1990; 14(8):731-3. PubMed ID: 2201824
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Retinoids in the treatment of acute promyelocytic leukemia. Review of the literature.
    Graf N; Riesinger P; Reinhard H
    Klin Padiatr; 1995; 207(2):43-7. PubMed ID: 7752598
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Fundamentals of chemo-differentiation therapy of myeloid leukemia.
    Hozumi M
    Anticancer Res; 1994; 14(3A):1177-92. PubMed ID: 8074470
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Sequential high-dose ara-C and asparaginase in the therapy of previously treated and untreated patients with acute leukemia.
    Capizzi RL; Powell BL; Cooper MR; Stuart JJ; Muss HB; Richards F; Jackson DV; White DR; Spurr CL; Zekan PJ
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):105-13. PubMed ID: 3892697
    [No Abstract]   [Full Text] [Related]  

  • 73. Teniposide: a review of 12 years of experience.
    O'Dwyer PJ; Alonso MT; Leyland-Jones B; Marsoni S
    Cancer Treat Rep; 1984 Dec; 68(12):1455-66. PubMed ID: 6391663
    [No Abstract]   [Full Text] [Related]  

  • 74. [The therapy of myelodysplastic syndromes].
    Aul C; Heyll A
    Dtsch Med Wochenschr; 1990 Nov; 115(48):1842-50. PubMed ID: 2245768
    [No Abstract]   [Full Text] [Related]  

  • 75. Molecular targets and the treatment of myeloid leukemia.
    Ikeda A; Shankar DB; Watanabe M; Tamanoi F; Moore TB; Sakamoto KM
    Mol Genet Metab; 2006 Jul; 88(3):216-24. PubMed ID: 16678459
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Homoharringtonine--perspectives on an active new natural product.
    O'Dwyer PJ; King SA; Hoth DF; Suffness M; Leyland-Jones B
    J Clin Oncol; 1986 Oct; 4(10):1563-8. PubMed ID: 3531426
    [No Abstract]   [Full Text] [Related]  

  • 77. Differentiation factors.
    Gabrilove JL
    Semin Oncol; 1986 Jun; 13(2):228-33. PubMed ID: 3520829
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.